About 40% of patients in the University of Colorado Health system who were prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist over a nearly 4 year time span did not fill the prescription, according to a research letter in JAMA Health Forum. Researchers analyzed 9,848 orders for 6,094 unique patients between January 2018 and September 2022, finding that overall, 5,915 (60.1%) orders were filled within 90-days. Patients with both diabetes and obesity were more likely to …
Read More